TELA Bio, Inc. (TELA) Misses Q1 EPS by 5c

TELA Bio, Inc. (NASDAQ: TELA) reported Q1 EPS of ($0.21), $0.05 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $19.1 million versus the consensus estimate of $21.28 million.

For earnings history and earnings-related data on TELA Bio, Inc. (TELA) click here.

You May Also Be Interested In

• UBS Upgrades Smoore International Holdings Limited (6969:HK) (SMORF) to Buy
• Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK275 at JPMorgan
• UBS Upgrades Geely Automotive Holdings Ltd. (175:HK) (GELYF) to Buy